High-Risk Obesity Phenotypes: Target for Multimorbidity Prevention at the ROFEMI Study

Carretero-Gómez, Juana; Pérez‐Martínez, Pablo; Seguí-Ripoll, José; Carrasco-Sánchez, Francisco Javier; Martínez, Nagore Lois; Pérez, E Rodríguez; Hernández, Onán Pérez; Ordoñez, Miguel García; Martín-González, Candelaria; Vigueras-Pérez, Juan; Puchades, Francesc; Avaria, María Blasco; Soto, María Pérez; Ena, Javier; Arévalo-Lorido, José Carlos

doi:10.3390/jcm11164644

Cited by 6 publications

(1 citation statement)

References 35 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The group of patients with HF showed a significantly more frequent occurrence of obesity diagnosed by BMI. This may indicate that sarcopenic obesity may be a more frequent clinical problem than sarcopenia among geriatric patients with HF [ 28 ]. Malnutrition significantly worsens the quality of life and the prognosis of HF patients [ 29 ].…”

Section: Discussionmentioning

confidence: 99%

Association of Chronic Heart Failure with Frailty, Malnutrition, and Sarcopenia Parameters in Older Patients—A Cross-Sectional Study in a Geriatric Ward

Charkiewicz¹,

Wojszel

Kasiukiewicz

et al. 2023

JCM

View full text Add to dashboard Cite

The need to assess sarcopenia and frailty in patients with chronic heart failure (HF) has recently been raised. This cross-sectional study of 416 geriatric ward patients (median age (Me)—82 (IQR, 77–86) years, 77.4% female, 96.9% community dwelling) aimed to assess the prevalence of dynapenia, frailty syndrome, functional and nutritional health, and co-morbidity regarding their HF status. We collected data from comprehensive geriatric assessment. We observed HF in 162 (38.9%) patients, with 80 (49.4%) classified as New York Heart Association (NYHA) class III or IV. HF patients were significantly older, more frequently male, obese, hospitalized in the previous year, burdened with multimorbidity and polypharmacy, classified as frail, dependent on daily living activities, and physically non-active. Ischemic heart disease, atrial fibrillation, diabetes, peripheral arterial disease, anemia, chronic kidney disease, history of myocardial infarction, and stroke were found significantly more often in the HF group. A considerably higher percentage of HF patients had dynapenia (54.9% versus 41.9%, p = 0.02), but the difference was significant only in women. We found no significant difference between HF and no-HF groups regarding muscle performance, except for lower median gait speed in the HF group—0.53 m/s (0.35–0.89 m/s) versus 0.68 m/s (0.44–0.99 m/s), p = 0.02). HF patients significantly more often had low grip strength accompanied by slow gait, suggesting probable severe sarcopenia (40.4% vs. 29% in patients without HF, p = 0.046). In the regression analysis, significantly higher odds for HF were observed for lower mid-arm circumference (MAC) and dynapenia when controlling for age, sex, body mass index (BMI), calf circumference (CC), peripheral arterial disease, history of stroke, ischemic heart disease, atrial fibrillation, and diabetes mellitus. Conclusions: HF geriatric patients are often burdened with frailty, obesity, multimorbidity, and polypharmacy. As a result, they are more likely to present low muscle strength (potential sarcopenia), which is frequently accompanied by functional limitations (suggestive of more advanced stages of sarcopenia). This tendency is evident mainly in older women. Nevertheless, sarcopenia can be independently associated with HF in older patients with multimorbidity and disability who are hospitalized in a geriatric department, as a multivariable logistic regression analysis demonstrated.

show abstract

Section: Discussionmentioning

confidence: 99%